William A Preston, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 700 W Forest Ave, Ste 300, Jackson, TN 38301 Phone: 731-422-0340 Fax: 731-422-0297 |
Dr. Karl Eric Studtmann, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 619 Skyline Dr, Jackson, TN 38301 Phone: 731-424-3682 Fax: 731-423-2714 |
Dr. William Keith Wainscott, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 619 Skyline Dr, Jackson, TN 38301 Phone: 731-424-3682 Fax: 731-423-2714 |
Dr. Robert Douglas Fowler, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 145 Innovation Dr, Jackson, TN 38305 Phone: 731-422-0213 Fax: 731-422-0297 |
Ronald H Kirkland, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 700 W Forest Ave, Ste 300, Jackson, TN 38301 Phone: 731-422-0340 Fax: 731-422-0297 |
Khwaja A Ahmed, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 145 Innovation Dr, Jackson, TN 38305 Phone: 731-422-0213 Fax: 731-422-0297 |
News Archive
A study released on Monday found that between 26 percent and 44 percent of artemisinin-based malaria drugs sold in Madagascar, Senegal and Uganda "failed quality testing" because of impurities or insufficient amounts of active ingredient, the Associated Press reports.
Ceram, the independent materials technology company, has recently helped Greatbatch Medical, providers of critical technologies used in medical devices, to gain FDA acceptance of its hydroxyapatite coating master file by providing all the necessary testing on the coating for a 510(k) implant submission.
Can people's differing reactions to situations of stress be attributed at least in part to genetic differences and do those differences affect men and women in different ways - with the edge seemingly favoring the women? Research conducted at the Hebrew University of Jerusalem would seem to indicate that the answer to both questions is yes.
The KYOTO HEART Study, which took place in Japan between January 2004 and January 2009, shows that the addition of valsartan to conventional antihypertensive treatment to improve blood pressure control is associated with an improved cardiovascular outcome in Japanese hypertensive patients at high risk of CVD events.
› Verified 5 days ago